.BETA.-AMYLOID PROTEIN-(1-6)-PEPTIDYLGLYCYLGLYCYL-L-CYSTEINE-3-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROLE-1-YL)-N-(6-((2,5-DIOXOPYRROLIDIN-1-YL)OXY)-6-OXOHEXYL)PROPANAMIDE-LYSINE
UNII VXW55WQ4I6
Substance Identification & Data
This profile provides standardized clinical and technical data for .beta.-amyloid Protein-(1-6)-peptidylglycylglycyl-l-cysteine-3-(2,5-dioxo-2,5-dihydro-1h-pyrrole-1-yl)-n-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)propanamide-lysine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VXW55WQ4I6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C59H88N18O20S JTAPVIVABNFKBM-ULFFCLSASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for .beta.-amyloid Protein-(1-6)-peptidylglycylglycyl-l-cysteine-3-(2,5-dioxo-2,5-dihydro-1h-pyrrole-1-yl)-n-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)propanamide-lysine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.